Vitamin D and vitamin K are two fat-soluble vitamins that play fundamental roles in human physiology, particularly in calcium metabolism. While each nutrient has distinct biological functions, emerging research highlights a synergistic relationship between vitamin D3 (cholecalciferol) and vitamin K2 (menaquinone) that may be critical for optimising bone health and maintaining cardiovascular integrity.
Understanding how these nutrients interact provides important insight into why correct formulation—rather than isolated supplementation—may be more physiologically relevant.
Vitamin D3 is a secosteroid hormone precursor synthesised in the skin following ultraviolet B (UVB) exposure or obtained through dietary intake and supplementation. Once activated in the liver and kidneys, it becomes 1,25-dihydroxyvitamin D (calcitriol), the hormonally active form.
Its primary physiological roles include:
Enhancing intestinal absorption of calcium and phosphorus
Regulating bone remodelling through osteoblast and osteoclast activity
Supporting immune function and cellular differentiation
Vitamin D is essential for maintaining calcium homeostasis. Without sufficient levels, calcium absorption efficiency decreases significantly, impairing bone mineralisation and increasing the risk of skeletal disorders such as osteopenia and osteoporosis (1) .
However, while vitamin D3 increases calcium availability in the bloodstream, it does not determine where that calcium is ultimately deposited.
Vitamin K exists in multiple forms, with vitamin K2 (menaquinone) being particularly important for extrahepatic functions, including bone and vascular health.
Vitamin K2 acts as a cofactor for the enzyme γ-glutamyl carboxylase, which activates vitamin K-dependent proteins such as:
Osteocalcin – involved in binding calcium to the bone matrix
Matrix Gla Protein (MGP) – inhibits calcium deposition in soft tissues and arteries
Without sufficient vitamin K2, these proteins remain inactive, impairing calcium utilisation and increasing the risk of ectopic calcification (2) .
Vitamin K2 has therefore been described as a key regulator of calcium distribution, ensuring calcium is directed into bones rather than accumulating in vascular tissues.
The interaction between vitamin D3 and K2 is not simply additive—it is biochemically interdependent.
Vitamin D3:
Increases calcium absorption
Stimulates the production of vitamin K-dependent proteins such as osteocalcin
Vitamin K2:
Activates these proteins through carboxylation
Directs calcium into bone and away from soft tissues
This coordinated mechanism has been described as a “nutrient synergy”, where vitamin D initiates the process and vitamin K2 completes it (3) . This is why many formulations now combine these nutrients into a single Vitamin D3 + K2 supplement designed to support proper calcium utilisation.
Importantly, vitamin D-dependent proteins are ineffective unless vitamin K is present to activate them. This means that elevated vitamin D levels alone may not fully support optimal calcium utilisation.
One of the most discussed concepts in the literature is the so-called “calcium paradox”—a phenomenon in which calcium accumulates in soft tissues (e.g., arteries) while bones become demineralised.
This paradox may arise when:
Calcium intake is high
Vitamin D increases calcium absorption
Vitamin K2 status is insufficient
In this scenario, calcium may not be efficiently incorporated into bone, increasing the risk of vascular calcification and reduced bone density.
Vitamin K2 plays a protective role by activating matrix Gla protein (MGP), which inhibits calcium deposition in arterial walls (2) .
A growing body of research suggests that combined vitamin D and K supplementation may be more effective for bone health than either nutrient alone.
Mechanistically:
Vitamin D enhances osteoblast activity and increases osteocalcin production
Vitamin K2 activates osteocalcin, allowing it to bind calcium to bone
Studies in both animal and human models indicate that the combined supplementation of vitamin D and vitamin K can improve bone mineral density (BMD) and reduce markers of bone loss, particularly in populations at risk of osteoporosis (4)
A review of multiple studies found that the majority demonstrated improved bone outcomes when vitamins D and K were used together, including reductions in fracture risk and improvements in bone quality (5) .
Additionally, experimental data show that vitamin D stimulates osteoblast gene expression, while vitamin K enhances the functionality of bone proteins, further supporting their complementary roles (3) .
Beyond bone health, the interaction between vitamin D3 and K2 has important implications for cardiovascular function.
Vascular calcification is a key contributor to conditions such as atherosclerosis and arterial stiffness. Vitamin K2 plays a critical role in preventing this process by activating MGP, which inhibits calcium deposition in blood vessels (2) .
Emerging evidence suggests that:
Vitamin K2 supplementation may reduce arterial stiffness
It may slow the progression of coronary artery calcification
Combined D3 + K2 supplementation may provide protective effects against cardiovascular disease
(6, 7)
Vitamin D alone has shown mixed results in cardiovascular outcomes, suggesting that calcium regulation—not just calcium absorption—is key.
This highlights the importance of considering nutrient interactions rather than isolated supplementation.
Vitamin D3 and vitamin K2 may be particularly relevant for individuals with limited sun exposure, dietary insufficiencies, or increased nutritional demands. This includes those who spend significant time indoors, older adults, and individuals with restricted dietary intake of vitamin K-rich foods.
In these cases, ensuring adequate intake through diet or a high-quality Vitamin D3 + K2 formula may help support calcium utilisation, bone health, and overall wellbeing.
At a molecular level, the synergy between vitamin D3 and K2 is driven by gene expression and protein activation:
Vitamin D receptor (VDR) activation
Vitamin D binds to the VDR, influencing the transcription of genes involved in calcium metabolism.
Upregulation of vitamin K-dependent proteins
Vitamin D increases the synthesis of osteocalcin and MGP.
Carboxylation by vitamin K2
Vitamin K2 activates these proteins, enabling them to bind calcium effectively.
Without vitamin K2, these proteins remain in an inactive (uncarboxylated) form, reducing their biological effectiveness (3) .
This illustrates why simply increasing calcium intake or vitamin D levels may not be sufficient for optimal physiological outcomes.
Vitamin D deficiency is widespread globally due to:
Limited sun exposure
Indoor lifestyles
Seasonal variation
Skin pigmentation differences
Low vitamin D levels are associated with impaired calcium absorption and reduced bone mineralisation.
Vitamin K2 intake is often lower than optimal, particularly in Western diets. Major dietary sources include:
Fermented foods (e.g., natto)
Aged cheeses
Certain animal products
Because K2 intake varies significantly between populations, suboptimal status may contribute to impaired calcium regulation.
While combining vitamin D3 and K2 is increasingly common, current evidence does not yet mandate universal co-supplementation.
However, research suggests that:
The combination may improve calcium utilisation
It may support both skeletal and cardiovascular health
It may be particularly relevant in populations at risk of deficiency or imbalance
(8)
It is important to note that vitamin K interacts with certain medications, particularly anticoagulants, and individual requirements may vary.
The combined role of vitamin D3 and K2 is an active area of research, with ongoing studies exploring their effects on:
Bone mineral density and fracture risk
Arterial stiffness and vascular calcification
Inflammation and metabolic health
Recent clinical investigations suggest that the combination may influence inflammatory pathways and cardiovascular markers, although further large-scale trials are required to confirm these findings (9) .
Overall, the current evidence supports a model in which nutrient synergy plays a central role in physiological regulation, particularly in systems as complex as calcium metabolism.
Vitamin D3 and vitamin K2 are essential nutrients with distinct yet interconnected roles in human health. While vitamin D3 increases calcium absorption and supports bone formation, vitamin K2 ensures that calcium is properly utilised—directing it into bone tissue and preventing its accumulation in soft tissues.
The scientific literature increasingly supports the concept that these vitamins function as part of a coordinated biological system, rather than as isolated nutrients.
Understanding this relationship highlights an important principle in nutrition science:
the effectiveness of a nutrient often depends on the presence of its biological cofactors.
References
Zarzour, F., Didi, A., Almohaya, M., Kendler, D. (2023). Cardiovascular Impact of Calcium and Vitamin D Supplements: A Narrative Review. Endocrinology and Metabolism, 38(1), 56–68.
Hariri E, Kassis N, Iskandar J, Schurgers LJ, Saad A, Abdelfattah O, et al. Vitamin K2—a neglected player in cardiovascular health: a narrative review. Open Heart. 2021;8:e001715. https://doi.org/10.1136/openhrt-2021-001715
van Ballegooijen, A. J., Pilz, S., Tomaschitz, A., Grübler, M. R., & Verheyen, N. (2017). The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review. International journal of endocrinology, 2017, 7454376. https://doi.org/10.1155/2017/7454376
Kuang, X., Liu, C., Guo, X., Li, K., Deng, Q., & Li, D. (2020). The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials. Food & function, 11(4), 3280–3297. https://doi.org/10.1039/c9fo03063h
Singh, V. et al. (2022) ‘Studies on the synergistic interplay of vitamin D and K for improving bone and Cardiovascular Health’, Current Research in Nutrition and Food Science Journal, 10(3), pp. 840–857. doi:10.12944/crnfsj.10.3.3.
D’Elia, S., Bottino, R., Carbone, A., Formisano, T., Orlandi, M., Sperlongano, S., Castaldo, P., Molinari, D., Palladino, A., Morello, M., Titolo, G., Loffredo, F. S., Natale, F., Cirillo, P., & Cimmino, G. (2026). Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties. International Journal of Molecular Sciences, 27(1), 298. https://doi.org/10.3390/ijms27010298
Hasific, S., Øvrehus, K. A., Hosbond, S., Lambrechtsen, J., Kumarathurai, P., Mejldal, A., Ravn, E. J., Rasmussen, L. M., Gerke, O., Mickley, H., & Diederichsen, A. (2023). Effects of vitamins K2 and D3 supplementation in patients with severe coronary artery calcification: a study protocol for a randomised controlled trial. BMJ open, 13(7), e073233. https://doi.org/10.1136/bmjopen-2023-073233
Khandelwal, A., Ahmed, K. A., & Dikshit, P. (2025). Vitamin D and Vitamin K: Synergistic Roles and Emerging Evidence for Combined Supplementation. Journal of mid-life health, 16(4), 505–508. https://doi.org/10.4103/jmh.jmh_169_25
Hasific, S. et al. (2025) ‘Effects of vitamin K2 and D3 Supplementation on epicardial adipose tissue and systemic inflammation: A substudy of the AVADEC trial’, Atherosclerosis, 410, p. 120540. doi:10.1016/j.atherosclerosis.2025.120540.
No comments